Onyx Bridge Wealth Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
AIM
CWP
DADC
WG
Onyx Bridge Wealth Group's PFE Position: Q2 2026 in Review
Onyx Bridge Wealth Group reduced its Pfizer (PFE) stake by 1.8% in Q2 2026, selling an estimated $23.4K and leaving 48,247 shares worth $1.16M. The position accounts for 0.1% of the portfolio, ranked #141.
Onyx Bridge Wealth Group first reported a position in PFE in Q1 2021 and has held it in 22 quarters since. The position peaked at $1.38M in Q1 2026. 991 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Onyx Bridge Wealth Group held 48,247 shares of Pfizer worth $1.16M as of Q2 2026.
- Onyx Bridge Wealth Group sold 894 Pfizer shares in Q2 2026, an estimated $23.4K.
- Pfizer made up 0.1% of Onyx Bridge Wealth Group's portfolio in Q2 2026, its #141 holding.
- Onyx Bridge Wealth Group first reported a position in Pfizer in Q1 2021 and has held it in 22 quarters since.
- Onyx Bridge Wealth Group's Pfizer position peaked at $1.38M in Q1 2026.
- 991 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Onyx Bridge Wealth Group's 13F filing for Q2 2026, filed 23 Jul 2026.